AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.8000
+0.0800 (+1.69%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close4.7200
Open4.7300
Bid4.7000 x 1300
Ask4.9000 x 2200
Day's Range4.6300 - 4.8550
52 Week Range1.8700 - 9.2900
Volume588,065
Avg. Volume803,868
Market Cap494.678M
Beta (3Y Monthly)1.63
PE Ratio (TTM)N/A
EPS (TTM)-3.5220
Earnings DateSep 16, 2019 - Sep 20, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • GlobeNewswire

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

    Pomerantz LLP is investigating claims on behalf of investors of  Amyris, Inc.  (“Amyris” or the “Company”) (NASDAQ: AMRS).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. On this news, Amyris’s stock price fell $1.76 per share, or 29.83%, to close at $4.14 per share on November 14, 2018.

  • PR Newswire

    Scott+Scott Attorneys at Law LLP Continues Investigation into Amyris, Inc.'s Directors and Officers for Breach of Fiduciary Duty - (NASDAQ: AMRS)

    NEW YORK , Sept. 9, 2019 /PRNewswire/ --  Scott+Scott Attorneys at Law LLP  ("Scott+Scott"), a national securities and consumer rights litigation firm, continues to investigate whether certain ...

  • Amyris Launches Pipette, a Clean Baby Care Brand Delivering a Critical Need for a Growing Market
    PR Newswire

    Amyris Launches Pipette, a Clean Baby Care Brand Delivering a Critical Need for a Growing Market

    EMERYVILLE, Calif., Sept. 4, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leader in the development and production of sustainable ingredients for the Flavors & Fragrances, Health & Wellness and Clean Beauty markets, announces the official launch of Pipette today. Since its launch, Biossance has brought the best-performing skincare products to the market and continues to define the industry standard for clean beauty. In response to parents asking for better-performing, safer products for their babies, Amyris conceived Pipette: a new Amyris brand reinventing clean personal care for babies and moms using the fewest possible ingredients from the purest sources.

  • PR Newswire

    Amyris to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019

    Amyris will provide an update on the progress and performance of its business during the presentation, which is scheduled for Monday, September 9, at 9:10 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company's website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.

  • PR Newswire

    Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amyris, Inc. (AMRS)

    NEW YORK, Aug. 28, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amyris, Inc. ("Amyris" or "the Company") (AMRS). The investigation concerns whether Amyris and certain of its officers and/or directors have violated federal securities laws. On November 13, 2018, Amyris reported disappointing financial results for the third quarter of 2018, including revenue of $14.9 million compared to $22.5 million in the prior year period, citing the "volatility of the Vitamin E market." On this news, Amyris's stock price fell $1.76 per share, or 29.83%, to close at $4.14 per share on November 14, 2018.

  • Meet 3 Companies that Are Shaping the Future of Food
    Motley Fool

    Meet 3 Companies that Are Shaping the Future of Food

    Beyond Meat is just the beginning of a new emerging cohort of innovative companies. These innovators are changing how we feed the planet without consuming more of its resources.

  • PR Newswire

    Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

    EMERYVILLE, Calif., Aug. 22, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended June 30, 2019, and because it remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2018 and its quarterly report on Form 10-Q for the quarter ended March 31, 2019, it is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission. The Nasdaq notice has no immediate effect on the listing or trading of Amyris's common stock on the Nasdaq Global Select Market.

  • Business Wire

    Scott+Scott Attorneys at Law LLP Continues Investigation into Amyris, Inc.’s Directors and Officers for Breach of Fiduciary Duty – (NASDAQ: AMRS)

    Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Amyris, Inc. (“Amyris” or the “Company”) (AMRS) breached their fiduciary duties to the Company and its shareholders. If you are an Amyris shareholder, you are encouraged to contact attorney Joe Pettigrew toll-free at (844) 818-6982 or at jpettigrew@scott-scott.com. Scott+Scott is investigating whether Amyris and its directors and officers made, or allowed Amyris to make, false and/or misleading statements to the investing public.

  • Benzinga

    Lavvan Appoints Former MedReleaf CEO Neil Closner To Its C-Suite

    Lavvan announced the appointment of Neil Closner as its new chief executive officer on Thursday. Closner left his position as CEO of MedReleaf and will be joining Lavvan's team along with seven other members of MedReleaf’s leadership team, Lavvan said in a press release. The company is collaborating with Amyris (NASDAQ: AMRS) on the development of fermentation-based technology that will add knowledge to the way cannabinoids can be applied within the industry.

  • Business Wire

    LAVVAN Appoints Neil Closner as Chief Executive Officer

    LAVVAN Inc. (“LAVVAN”) today announced that Neil Closner, formerly of MedReleaf Corp. ("MedReleaf"), has been appointed its new Chief Executive Officer. Former LAVVAN CEO, Etan Bendheim, will become President of the company. Closner has more than two decades of start-up, technology and health care experience.

  • PR Newswire

    Amyris to Host Business Update Teleconference and Webcast on Monday, August 5, 2019

    EMERYVILLE, Calif., July 26, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS) will host a business update teleconference and webcast on Monday, August 5, 2019 prior to presenting at the Jefferies Global Industrials Conference in New York on August 6, following which the company plans to participate in investor meetings in New York and Boston through August 8. The purpose of the call is to discuss solid progress in the company's business thus far during 2019, provide updates on Amyris's brands, plant construction, debt, and status of working toward achieving filing compliance with the Securities & Exchange Commission. Participants should ask to be joined to the Amyris, Inc. call.

  • ADL Bionatur Solutions and Amyris Expand Contract to 2020
    PR Newswire

    ADL Bionatur Solutions and Amyris Expand Contract to 2020

    LEÓN, Spain and EMERYVILLE, Calif., July 19, 2019 /PRNewswire/ -- ADL Bionatur Solutions (MAB:ADL), a company specialized in research and development of sustainable health and beauty products, services and industrial fermentation production, announces today the expansion of its existing production agreement with Amyris, Inc. (AMRS). Amyris is a leader in the development and production of pure, sustainable, fermentation-derived ingredients for the Health & Clean Beauty markets.

  • PR Newswire

    Amyris to Participate in and Provide Business Update at Jefferies 2019 Global Industrials Conference

    EMERYVILLE, Calif., July 12, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it plans to participate in the following upcoming investor conference in August 2019. Amyris will provide an update on its business during the presentation. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company's website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth.

  • GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance Innovations, Amyris and Nutanix and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire is investigating certain officers and directors of Inogen, Inc., Health Insurance Innovations, Inc., Amyris, Inc., and Nutanix, Inc. More information about each potential case can be found at the link provided. Bragar Eagel and Squire is investigating certain officers and directors of Inogen following a class action complaint that was filed against Inogen on March 6, 2019.

  • Jonathan Van Ness Joins BIOSSANCE as First Celebrity Ambassador
    PR Newswire

    Jonathan Van Ness Joins BIOSSANCE as First Celebrity Ambassador

    EMERYVILLE, Calif., June 27, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that television personality, podcaster, comedian and beauty expert to the stars Jonathan Van Ness has joined Biossance as the first celebrity ambassador for the brand. The partnership with Jonathan Van Ness marks a milestone in visibility for the brand to advance its mission to make clean the new standard in beauty. "I love incorporating skincare that helps me feel and look my best, while also coming from ethical and sustainably sourced places," says Jonathan Van Ness.  "Since the start of my career in the beauty industry, I have been inspired by companies that blend nature and science to create skincare that helps improve the health of skin and people's knowledge of what the ingredients really do.

  • PR Newswire

    Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strains

    This is the first application of BLI's Beacon® platform for microbial strains within synthetic biology. The goal of the collaboration is to implement the Beacon platform to identify and isolate microbial strains that produce the highest quantities of non-therapeutic product.

  • PR Newswire

    Amyris Appoints Kathleen Valiasek Chief Business Officer-Appoints Jonathan Wolter as Interim CFO

    EMERYVILLE, Calif., June 4, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment of Kathleen Valiasek, formerly Chief Financial Officer, to Chief Business Officer effective immediately. Valiasek will assume a dedicated role of furthering the company's strategy of collaborating with large, well-funded partners to grow the company's business. Simultaneously, she will continue to oversee the company's financing and investor relations activities.

  • GlobeNewswire

    AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Deadline

    Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.

  • GlobeNewswire

    DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

  • ACCESSWIRE

    AMRS & CRCM -Deadline Alert - Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / June 3, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...